AACR 2025 Poster Presentation: Dual Blockade of EGFR and TGF-β With Ficerafusp Alfa Has the Potential to Overcome Resistance Mechanisms in 1L R/M HNSCC in Combination With[...]

Bicara Therapeutics Inc. published this content on April 28, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2025 at 10:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]